β₂-Microglobulin and the Kidney: An Overview

References

• Berggard I, Beam A G. Isolation and properties of a low molecular weight beta-2 microglobulin occurring in human biological fluids. J Biol Chem. 1968; 243: 4095
   PubMed Web of Science ®Google Scholar
• Solheim B G, Thorsby E. B-2 microglobulin. Part of the HLA molecule in the cell membrane. Tissue Antigens 1974; 4: 83
   PubMedGoogle Scholar
• Peterson P A, Cunningham B A, Berggard I, Edelman G M. B-2 microglobulin. A free immunoglobulin domain. Proc Natl Acad Sci USA 1972; 69: 1697
   PubMed Web of Science ®Google Scholar
• Wibell L, Evrin P E, Berggard I. Serum B-2 microglobulin in renal disease. Nephron. 1973; 10: 320
   PubMed Web of Science ®Google Scholar
• Stone W J. Hakin RM: Beta-2-microglobulin amyloidosis in long-term dialysis patients. Am J Nephrol. 1989; 9: 177
   PubMed Web of Science ®Google Scholar
• Odell R A, Slowiaczek P, Moran J A, Schindhelm K. Beta-2 microglobulin kinetics in end stage renal failure. Kidney Int. 1990; 39: 909
   Google Scholar
• Evrin P E, Wibell L. Serum B-2 microglobulin in various disorders. Clin Chim Acta. 1973; 43: 183
   PubMed Web of Science ®Google Scholar
• Bataille R, Grenier J. Serum Beta-2 microglobulin in multiple myeloma. A critical review. Am J Cancer Clin Oncol. 1987; 23: 1829
   PubMedGoogle Scholar
• Norfolk D, Child J A, Cooper E H, Kerruish S, Milford W A. Serum B-2 microglobulin in myelomatosis. Potential value in stratification and monitoring. Br J Cancer 1979; 39: 510
   PubMedGoogle Scholar
• Gorevic P D, Casey T T, Stone W J, DiRaimondo C R, Prelli F C, Frangione B. Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest. 1985; 76: 2425
   PubMed Web of Science ®Google Scholar
• Gejyo F, Odanill S, Yamada T, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen A, Schmid K. A new form of amyloid protein associated with hemodialysis was identified as beta-2 microglobulin. Biochem Biophys Res Commun. 1985; 129: 701
   PubMed Web of Science ®Google Scholar
• Gejyo F, Odani S, Yamada T, Honma N, Saito H, Suzuki Y, Nakagawa Y, Kobayashi H, Maruyama Y, Hirasawa Y, Suzuki M, Arakawa M. Beta-2 microglobulin. A new form of amyloid protein associated with chronic hemodialysis. Kidney Int. 1986; 30: 385
   PubMed Web of Science ®Google Scholar
• Gorevic P D, Munoz P C, Casey T T, DiRaimondo C R, Stone W J, Prelli F C, Rodrigues M M, Poulik M D, Frangione B. Polymerization of intact B-2 microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 1986; 83: 7908
   PubMed Web of Science ®Google Scholar
• Casey T T, Stone W J, DiRaimondo C R, Brantley B D, DiRaimondo C V, Gorevic P D, Page D L. Tumoral amyloidosis of bone of B-2 microglobulin origin in association with long-term hemodialysis. A new type of amyloid disease. Hum Pathol. 1986; 17: 731
   PubMed Web of Science ®Google Scholar
• Fuchs A, Jagirdar J, Schwartz I S. Beta-2 microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis. A new type of amyloid. Am J Clin Pathol. 1987; 88: 302
   PubMed Web of Science ®Google Scholar
• Ogawa H, Saito A, Oda O, Nakajima M, Chung T G. Detection of novel B-2 microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition. Clin Nephrol. 1988; 30: 158
   PubMed Web of Science ®Google Scholar
• Koch K M. Dialysis-related amyloidosis. Kidney Int. 1992; 41: 1416
   PubMed Web of Science ®Google Scholar
• Munoz-Gomez J, Gomez-Perez R, Llopart-Buisan E, Sole-Arques M. Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on hemodialysis using cellulose membranes. Ann Rheum Dis. 1987; 46: 573
   PubMed Web of Science ®Google Scholar
• Bardin T, Kuntz D, Zingraff J, Voisin M C, Zelmar A, Lansa-Man J. Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis Rheum. 1985; 28: 1052
   PubMed Web of Science ®Google Scholar
• Cuffe M J, Hadley M N, Herrera G A, Morawetz R B. Dialysis-associated spondyloarthyropathy. Report of nine cases. J Neurosurg. 1985; 28: 1052, In press.
   Google Scholar
• Ranvskov U, Johansson B G, Gothlin J. Renal extraction of B-2 microglobulin. Scand J Clin Lab Invest. 1972; 30: 71
   PubMedGoogle Scholar
• Maack T, Johnson V, Kau S T, Figueiredo J, Sigulem D. Renal filtration, transport and metabolism of low molecular weight proteins. A review. Kidney Int. 1979; 16: 251
   PubMed Web of Science ®Google Scholar
• Floege J, Wilks M F, Soose M, Koetzerke J, Shaldon S, Koch K M. Renal elimination of Beta-2 microglobulin and myoglobin in patients with normal and impaired renal function. Nephron. 1990; 55: 361
   PubMedGoogle Scholar
• Linke R P, Hampl H, Lobeck H, Ritz E, Bommer J, Waldherr R, Eulitz M. Lysine-specific cleavage of B-2 microglobulin in amyloid deposits associated with hemodialysis. Kidney Inr 1989; 36: 675
   PubMed Web of Science ®Google Scholar
• Honig R, Marsen T, Schad S, Barth C, Pollok M, Baldamus C A. Correlation of beta-2 microglobulin concentration changes to distribution volume. Int J Artif Organs 1988; 11: 459
   PubMedGoogle Scholar
• Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine M D, Haeffner-Cavaillon N. Induction of IL-1 during hemodialysis. Transmembrane passage of intact endotoxins (LPS). Kidney Int. 1990; 38: 1089
   PubMed Web of Science ®Google Scholar
• Dinarello C A, Mier J W. Current concepts. Lymphokines. N Engl J Med. 1987; 317: 940
   PubMed Web of Science ®Google Scholar
• Nachbaur K, Troppmair J, Kotlan B, Konig P, Aulitzky W, Bieling P, Huber C H. Cytokines in the control of beta-2 microglobulin release. II. In vitro studies on various hematopoietic cells. Immunobiology 1978; 177: 66
   Google Scholar
• Zaoui P M, Stone W J, Hakim R M. Effects of dialysis membranes on beta-2 microglobulin production and cellular expression. Kidney Int. 1990; 38: 962
   PubMedGoogle Scholar
• Jahn B, Deppisch R, Hansch G M, Ritz E. Enhanced synthesis of B-2 microglobulin (B2m) mRNA in lymphocytes after contact with cuprophane R in vitro and in vivo. J Am Soc Nephrol. 1990; 1: 362, Abstract.
   Google Scholar
• Zingraff J, Beyne P, Urena M, Uzan M, Nguyen Khoa M, Descamps-Latscha B, Drueke T. Influence of hemodialysis membranes on B-2 microglobulin kinetics: In vivo and in vitro studies. Nephrol Dial Transplant. 1988; 3: 284
   PubMedGoogle Scholar
• Gagnon R F, Lough J O, Bourgouin P A. Carpal tunnel syndrome and amyloidosis associated with continuous ambulatory peritoneal dialysis. Can Med Assoc J. 1988; 139: 753
   Google Scholar
• Jadoul M, Noel H, Van Ypersele de Strihou C A. B-2 microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1990; 15: 86
   PubMed Web of Science ®Google Scholar
• Argiles A, Mourad G, Atkins R C, Mion C H. New insights into the pathogenesis of hemodialysis-associated amyloidosis. Sem Dial. 1990; 3: 149
   Google Scholar
• Floege J, Nonnast-Daniel B, Gielow P, Brandis A, Spindler E, Hundeshagen H, Koch K M, Shaldon S. Specific imaging of dialysis-related amyloid deposits using 131-1-beta-2-microglobulin. Nephron. 1989; 51: 441
   PubMedGoogle Scholar
• Nishi S, Ogino S, Maruyama Y, Honma N, Gejyo F, Morita T, Arakawa M. Electron-microscopic and immunohisto-chemical study of beta-2 microglobulin-related amyloidosis. Nephron. 1990; 56: 357
   PubMed Web of Science ®Google Scholar